Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Theradaptive, Inc.”

3 pharma patents match "Theradaptive, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "Theradaptive, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “Theradaptive, Inc.” · 30,257 patents in full index Clear search

  1. US 12264187

    Compositions and methods for targeted therapeutic delivery to bone

    Theradaptive, Inc. · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted

  2. US 11773138

    Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

    Theradaptive, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  3. US 11192923

    Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

    Theradaptive, Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.